Genetics of the sudden infant death syndrome

Forensic Science International

Volumn 203, Issue 1-3, 2010, Pages 25-33

  Courts, Cornelius ^a   Madea, Burkhard ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Forensic genetics; Forensic science; SIDS; Sudden infant death syndrome; Triple risk model

Indexed keywords

ARTICLE; BACTERIAL INFECTION; ENVIRONMENTAL FACTOR; FORENSIC GENETICS; GASTROESOPHAGEAL REFLUX; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HUMAN; INFANT MORTALITY; INTRAUTERINE INFECTION; LONG QT SYNDROME; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SLEEP; SUDDEN INFANT DEATH SYNDROME;

EID: 78649330594     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.forsciint.2010.07.008     Document Type: Article

References (106)

1. J.B. Beckwith, Discussion of the terminology and definition of the sudden infant death syndrome (1970) pp. 14-22.
2. Krous H.F., Beckwith J.B., Byard R.W., Rognum T.O., Bajanowski T., Corey T., et al. Sudden infant death syndrome and unclassified sudden infant deaths: a definitional and diagnostic approach. Pediatrics 2004, 114(1):234-238.
3. Shapiro-Mendoza C.K., Tomashek K.M., Anderson R.N., Wingo J. Recent national trends in sudden, unexpected infant deaths: more evidence supporting a change in classification or reporting. Am. J. Epidemiol. 2006, 163(8):762-769.
4. Malloy M.H., MacDorman M. Changes in the classification of sudden unexpected infant deaths: United States, 1992-2001. Pediatrics 2005, 115(5):1247-1253.
5. Vennemann M., Bajanowski T., Butterfass-Bahloul T., Sauerland C., Jorch G., Brinkmann B., et al. Do risk factors differ between explained sudden unexpected death in infancy and sudden infant death syndrome?. Arch. Dis. Child 2007, 92(2):133-136.
6. Leach C.E., Blair P.S., Fleming P.J., Smith I.J., Platt M.W., Berry P.J., et al. Epidemiology of SIDS and explained sudden infant deaths. CESDI SUDI Research Group. Pediatrics 1999, 104(4):e43.
7. Platt M.W., Blair P.S., Fleming P.J., Smith I.J., Cole T.J., Leach C.E., et al. A clinical comparison of SIDS and explained sudden infant deaths: how healthy and how normal? CESDI SUDI Research Group. Confidential inquiry into stillbirths and deaths in infancy study. Arch. Dis. Child 2000, 82(2):98-106.
8. Opdal S.H., Rognum T.O. The sudden infant death syndrome gene: does it exist?. Pediatrics 2004, 114(4):e506-e512.
9. Mitchell E.A. The changing epidemiology of SIDS following the national risk reduction campaigns. Pediatr. Pulmonol. Suppl. 1997, 16117-16119.
10. Nicholl J.P., O'Cathain A. Epidemiology of babies dying at different ages from the sudden infant death syndrome. J. Epidemiol. Community Health 1989, 43(2):133-139.
11. Kleemann W.J., Bajanowski T. Plötzlicher Tod im Säuglings- und Kindesalter 2004, 1071-1128.
12. Douglas A.S., Allan T.M., Helms P.J. Seasonality and the sudden infant death syndrome during 1987-9 and 1991-3 in Australia and Britain. BMJ 1996, 312(7043):1381-1383.
13. Hauck F.R., Tanabe K.O. International trends in sudden infant death syndrome: stabilization of rates requires further action. Pediatrics 2008, 122(3):660-666.
14. Schwartz P.J., Priori S.G., Dumaine R., Napolitano C., Antzelevitch C., Stramba-Badiale M., et al. A molecular link between the sudden infant death syndrome and the long-QT syndrome. N. Engl. J. Med. 2000, 343(4):262-267.
15. Millat G., Kugener B., Chevalier P., Chahine M., Huang H., Malicier D., et al. Contribution of long-QT syndrome genetic variants in sudden infant death syndrome. Pediatr. Cardiol. 2009, 30(4):502-509.
16. Schwartz P.J., Stramba-Badiale M., Segantini A., Austoni P., Bosi G., Giorgetti R., et al. Prolongation of the QT interval and the sudden infant death syndrome. N. Engl. J. Med. 1998, 338(24):1709-1714.
17. Moric E., Herbert E., Trusz-Gluza M., Filipecki A., Mazurek U., Wilczok T. The implications of genetic mutations in the sodium channel gene (SCN5A). Europace 2003, 5(4):325-334.
18. Ackerman M.J., Siu B.L., Sturner W.Q., Tester D.J., Valdivia C.R., Makielski J.C., et al. Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome. JAMA 2001, 286(18):2264-2269.
19. Turillazzi E., La R.G., Anzalone R., Corrao S., Neri M., Pomara C., et al. Heterozygous nonsense SCN5A mutation W822X explains a simultaneous sudden infant death syndrome. Virchows Arch. 2008, 453(2):209-216.
20. Panigrahy A., Filiano J., Sleeper L.A., Mandell F., Valdes-Dapena M., Krous H.F., et al. Decreased serotonergic receptor binding in rhombic lip-derived regions of the medulla oblongata in the sudden infant death syndrome. J. Neuropathol. Exp. Neurol. 2000, 59(5):377-384.
21. Kinney H.C., Randall L.L., Sleeper L.A., Willinger M., Belliveau R.A., Zec N., et al. Serotonergic brainstem abnormalities in Northern Plains Indians with the sudden infant death syndrome. J. Neuropathol. Exp. Neurol. 2003, 62(11):1178-1191.
22. Paterson D.S., Trachtenberg F.L., Thompson E.G., Belliveau R.A., Beggs A.H., Darnall R., et al. Multiple serotonergic brainstem abnormalities in sudden infant death syndrome. JAMA 2006, 296(17):2124-2132.
23. Ozawa Y., Okado N. Alteration of serotonergic receptors in the brain stems of human patients with respiratory disorders. Neuropediatrics 2002, 33(3):142-149.
24. Kinney H.C., Richerson G.B., Dymecki S.M., Darnall R.A., Nattie E.E. The brainstem and serotonin in the sudden infant death syndrome. Annu. Rev. Pathol. 2009, 4517-4550.
25. Deixler E. Sudden infant death syndrome (SIDS) caused by ATP-depletion following hyperventilation, tissue-hypoxia and hypermetabolism-a hypothesis. Z. Geburtshilfe Neonatol. 2009, 213(4):122-134.
26. Thach B.T. Sudden infant death syndrome: can gastroesophageal reflux cause sudden infant death?. Am. J. Med. 2000, 108(Suppl.). 4a144S-148S.
27. Vege A., Rognum T.O. Inflammatory responses in sudden infant death syndrome - past and present views. FEMS Immunol. Med. Microbiol. 1999, 25(1-2):67-78.
28. Saadi A.T., Blackwell C.C., Raza M.W., James V.S., Stewart J., Elton R.A., et al. Factors enhancing adherence of toxigenic Staphylococcus aureus to epithelial cells and their possible role in sudden infant death syndrome. Epidemiol. Infect. 1993, 110(3):507-517.
29. Saadi A.T., Blackwell C.C., Essery S.D., Raza M.W., el Ahmer O.R., MacKenzie D.A., et al. Developmental and environmental factors that enhance binding of Bordetella pertussis to human epithelial cells in relation to sudden infant death syndrome (SIDS). FEMS Immunol. Med. Microbiol. 1996, 16(1):51-59.
30. el Ahmer O.R., Raza M.W., Ogilvie M.M., Weir D.M., Blackwell C.C. Binding of bacteria to HEp-2 cells infected with influenza A virus. FEMS Immunol. Med. Microbiol. 1999, 23(4):331-341.
31. Harrison L.M., Morris J.A., Telford D.R., Brown S.M., Jones K. Sleeping position in infants over 6 months of age: implications for theories of sudden infant death syndrome. FEMS Immunol. Med. Microbiol. 1999, 25(1-2):29-35.
32. Jakeman K.J., Rushton D.I., Smith H., Sweet C. Exacerbation of bacterial toxicity to infant ferrets by influenza virus: possible role in sudden infant death syndrome. J. Infect. Dis. 1991, 163(1):35-40.
33. Lundemose J.B., Smith H., Sweet C. Cytokine release from human peripheral blood leucocytes incubated with endotoxin with and without prior infection with influenza virus: relevance to the sudden infant death syndrome. Int. J. Exp. Pathol. 1993, 74(3):291-297.
34. Raza M.W., Essery S.D., Elton R.A., Weir D.M., Busuttil A., Blackwell C. Exposure to cigarette smoke, a major risk factor for sudden infant death syndrome: effects of cigarette smoke on inflammatory responses to viral infection and bacterial toxins. FEMS Immunol. Med. Microbiol. 1999, 25(1-2):145-154.
35. Raza M.W., Blackwell C.C. Sudden infant death syndrome, virus infections and cytokines. FEMS Immunol. Med. Microbiol. 1999, 25(1-2):85-96.
36. Highet A.R., Berry A.M., Goldwater P.N. Novel hypothesis for unexplained sudden unexpected death in infancy (SUDI). Arch. Dis. Child 2009, 94(11):841-843.
37. Vege A., Ole R.T. Sudden infant death syndrome, infection and inflammatory responses. FEMS Immunol. Med. Microbiol. 2004, 42(1):3-10.
38. Wedgwood R.J. Rev. USA Experience 1972, 28.
39. Filiano J.J., Kinney H.C. A perspective on neuropathologic findings in victims of the sudden infant death syndrome: the triple-risk model. Biol. Neonate 1994, 65(3-4):194-197.
40. Guntheroth W.G., Spiers P.S. The triple risk hypotheses in sudden infant death syndrome. Pediatrics 2002, 110(5):e64.
41. Lenoir C.P., Mallet E., Calenda E. Siblings of sudden infant death syndrome and near miss in about 30 families: is there a genetic factor?. Med. Hypotheses 2000, 54(3):408-411.
42. Oren J., Kelly D.H., Shannon D.C. Familial occurrence of sudden infant death syndrome and apnea of infancy. Pediatrics 1987, 80(3):355-358.
43. Beal S.M., Blundell H.K. Recurrence incidence of sudden infant death syndrome. Arch. Dis. Child 1988, 63(8):924-930.
44. Mitchell E.A. SIDS: past, present and future. Acta Paediatr. 2009, 98(11):1712-1719.
45. Zimmer T., Surber R. SCN5A channelopathies-an update on mutations and mechanisms. Prog. Biophys. Mol. Biol. 2008, 98(2-3):120-136.
46. Andresen B.S., Bross P., Jensen T.G., Knudsen I., Winter V., Kolvraa S., et al. Molecular diagnosis and characterization of medium-chain acyl-CoA dehydrogenase deficiency. Scand. J. Clin. Lab. Invest. 1995, (Suppl.):2209-2225.
47. Tryba A.K., Pena F., Ramirez J.M. Gasping activity in vitro: a rhythm dependent on 5-HT2A receptors. J. Neurosci. 2006, 26(10):2623-2634.
48. St-John W.M., Leiter J.C. Maintenance of gasping and restoration of eupnea after hypoxia is impaired following blockers of alpha1-adrenergic receptors and serotonin 5-HT2 receptors. J. Appl. Physiol. 2008, 104(3):665-673.
49. Audero E., Coppi E., Mlinar B., Rossetti T., Caprioli A., Banchaabouchi M.A., et al. Sporadic autonomic dysregulation and death associated with excessive serotonin autoinhibition. Science 2008, 321(5885):130-133.
50. Van Norstrand D.W., Tester D.J., Ackerman M.J. Overrepresentation of the proarrhythmic, sudden death predisposing sodium channel polymorphism S1103Y in a population-based cohort of African-American sudden infant death syndrome. Heart Rhythm 2008, 5(5):712-715.
51. Bradley S.R., Pieribone V.A., Wang W., Severson C.A., Jacobs R.A., Richerson G.B. Chemosensitive serotonergic neurons are closely associated with large medullary arteries. Nat. Neurosci. 2002, 5(5):401-402.
52. Penatti E.M., Berniker A.V., Kereshi B., Cafaro C., Kelly M.L., Niblock M.M., et al. Ventilatory response to hypercapnia and hypoxia after extensive lesion of medullary serotonergic neurons in newborn conscious piglets. J. Appl. Physiol. 2006, 101(4):1177-1188.
53. Darnall R.A., Harris M.B., Gill W.H., Hoffman J.M., Brown J.W., Niblock M.M. Inhibition of serotonergic neurons in the nucleus paragigantocellularis lateralis fragments sleep and decreases rapid eye movement sleep in the piglet: implications for sudden infant death syndrome. J. Neurosci. 2005, 25(36):8322-8332.
54. Feldman J.L., Mitchell G.S., Nattie E.E. Breathing: rhythmicity, plasticity, chemosensitivity. Annu. Rev. Neurosci 2003, 26239-26266.
55. Lesch K.P., Balling U., Gross J., Strauss K., Wolozin B.L., Murphy D.L., et al. Organization of the human serotonin transporter gene. J. Neural. Transm. Gen. Sect. 1994, 95(2):157-162.
56. Heils A., Teufel A., Petri S., Stober G., Riederer P., Bengel D., et al. Allelic variation of human serotonin transporter gene expression. J. Neurochem. 1996, 66(6):2621-2624.
57. Weese-Mayer D.E., Zhou L., Berry-Kravis E.M., Maher B.S., Silvestri J.M., Marazita M.L. Association of the serotonin transporter gene with sudden infant death syndrome: a haplotype analysis. Am. J. Med. Genet. A 2003, 122A(3):238-245.
58. Wallace D.C. Mitochondrial DNA sequence variation in human evolution and disease. Proc. Natl. Acad. Sci. U.S.A. 1994, 91(19):8739-8746.
59. Iyasu S., Randall L.L., Welty T.K., Hsia J., Kinney H.C., Mandell F., et al. Risk factors for sudden infant death syndrome among northern plains Indians. JAMA 2002, 288(21):2717-2723.
60. Hauck F.R., Herman S.M., Donovan M., Iyasu S., Merrick M.C., Donoghue E., et al. Sleep environment and the risk of sudden infant death syndrome in an urban population: the Chicago Infant Mortality Study. Pediatrics 2003, 111(5 (Part 2)):1207-1214.
61. Molteno C.D., Ress E., Kibel M.A. Early childhood mortality in Cape Town. S. Afr. Med. J. 1989, 75(12):570-574.
62. Ford R.P., Nelson K.P. Higher rates of SIDS persist in low income groups. J. Paediatr. Child Health 1995, 31(5):408-411.
63. Mitchell E.A., Brunt J.M., Everard C. Reduction in mortality from sudden infant death syndrome in New Zealand: 1986-92. Arch. Dis. Child 1994, 70(4):291-294.
64. Blood-Siegfried J., Nyska A., Lieder H., Joe M., Vega L., Patterson R., et al. Synergistic effect of influenza a virus on endotoxin-induced mortality in rat pups: a potential model for sudden infant death syndrome. Pediatr. Res. 2002, 52(4):481-490.
65. Guntheroth W.G. Homing in on a SIDS model. Science 2008, 322(5903):856-857.
66. Pavone L.M., Spina A., Rea S., Santoro D., Mastellone V., Lombardi P., et al. Serotonin transporter gene deficiency is associated with sudden death of newborn mice through activation of TGF-beta1 signalling. J. Mol. Cell. Cardiol. 2009, 47(5):691-697.
67. Lecoq I., Mallet E., Bonte J.B., Laroche D., Travert G. Screening of A985 to G mutation of medium-chain acyl-CoA dehydrogenase (MCAD) gene in Normandy. Evaluation of the role of MCAD deficiency in sudden infant death. C R Seances Soc. Biol. Fil. 1995, 189(2):295-301.
68. Penzien J.M., Molz G., Wiesmann U.N., Colombo J.P., Buhlmann R., Wermuth B. Medium-chain acyl-CoA dehydrogenase deficiency does not correlate with apparent life-threatening events and the sudden infant death syndrome: results from phenylpropionate loading tests and DNA analysis. Eur. J. Pediatr. 1994, 153(5):352-357.
69. Arens R., Gozal D., Jain K., Muscati S., Heuser E.T., Williams J.C., et al. Prevalence of medium-chain acyl-coenzyme A dehydrogenase deficiency in the sudden infant death syndrome. J. Pediatr. 1993, 122(5 (Pt 1)):715-718.
70. Dundar M., Lanyon W.G., Connor J.M. Scottish frequency of the common G985 mutation in the medium-chain acyl-CoA dehydrogenase (MCAD) gene and the role of MCAD deficiency in sudden infant death syndrome (SIDS). J. Inherit. Metab. Dis. 1993, 16(6):991-993.
71. Miller M., Brooks J., Forbes N., Insel R. Frequency of G-985 mutation in medium chain acyl-coenzyme A dehydrogenase (MCAD) deficiency in sudden infant death syndrome (SIDS). Prog. Clin. Biol. Res. 1992, 375495-375498.
72. Miller M.E., Brooks J.G., Forbes N., Insel R. Frequency of medium-chain acyl-CoA dehydrogenase deficiency G-985 mutation in sudden infant death syndrome. Pediatr. Res. 1992, 31(4 Pt 1):305-307.
73. Narita N., Narita M., Takashima S., Nakayama M., Nagai T., Okado N. Serotonin transporter gene variation is a risk factor for sudden infant death syndrome in the Japanese population. Pediatrics 2001, 107(4):690-692.
74. Weese-Mayer D.E., Berry-Kravis E.M., Maher B.S., Silvestri J.M., Curran M.E., Marazita M.L. Sudden infant death syndrome: association with a promoter polymorphism of the serotonin transporter gene. Am. J. Med. Genet. A 2003, 117A(3):268-274.
75. Opdal S.H., Vege A., Rognum T.O. Serotonin transporter gene variation in sudden infant death syndrome. Acta Paediatr. 2008, 97(7):861-865.
76. Nonnis M.F., Maldini M., Filonzi L., Lavezzi A.M., Parmigiani S., Magnani C., et al. Genes regulating the serotonin metabolic pathway in the brain stem and their role in the etiopathogenesis of the sudden infant death syndrome. Genomics 2008, 91(6):485-491.
77. Haas C., Braun J., Bar W., Bartsch C. No association of serotonin transporter gene variation with sudden infant death syndrome (SIDS) in Caucasians. Leg. Med. (Tokyo) 2009, 11(Suppl. 1):S210-S212.
78. Maher B.S., Marazita M.L., Rand C., Zhou L., Berry-Kravis E.M., Weese-Mayer D.E. 3′ UTR polymorphism of the serotonin transporter gene and sudden infant death syndrome: haplotype analysis. Am. J. Med. Genet. A 2006, 140(13):1453-1457.
79. Rand C.M., Berry-Kravis E.M., Fan W., Weese-Mayer D.E. HTR2A variation and sudden infant death syndrome: a case-control analysis. Acta Paediatr. 2009, 98(1):58-61.
80. Filonzi L., Magnani C., Lavezzi A.M., Rindi G., Parmigiani S., Bevilacqua G., et al. Association of dopamine transporter and monoamine oxidase molecular polymorphisms with sudden infant death syndrome and stillbirth: new insights into the serotonin hypothesis. Neurogenetics 2009, 10(1):65-72.
81. Weese-Mayer D.E., Berry-Kravis E.M., Zhou L., Maher B.S., Curran M.E., Silvestri J.M., et al. Sudden infant death syndrome: case-control frequency differences at genes pertinent to early autonomic nervous system embryologic development. Pediatr. Res. 2004, 56(3):391-395.
82. Kijima K., Sasaki A., Niki T., Umetsu K., Osawa M., Matoba R., et al. Sudden infant death syndrome is not associated with the mutation of PHOX2B gene, a major causative gene of congenital central hypoventilation syndrome. Tohoku J. Exp. Med. 2004, 203(1):65-68.
83. Klintschar M., Reichenpfader B., Saternus K.S. A functional polymorphism in the tyrosine hydroxylase gene indicates a role of noradrenalinergic signaling in sudden infant death syndrome. J. Pediatr. 2008, 153(2):190-193.
84. Opdal S.H., Vege A., Saugstad O.D., Rognum T.O. Is partial deletion of the complement C4 genes associated with sudden infant death?. Eur. J. Pediatr. 1994, 153(4):287-290.
85. Opdal S.H., Vege A., Stave A.K., Rognum T.O. The complement component C4 in sudden infant death. Eur. J. Pediatr. 1999, 158(3):210-212.
86. Schneider P.M., Wendler C., Riepert T., Braun L., Schacker U., Horn M., et al. Possible association of sudden infant death with partial complement C4 deficiency revealed by post-mortem DNA typing of HLA class II and III genes. Eur. J. Pediatr. 1989, 149(3):170-174.
87. Keller E., Andreas A., Teifel-Greding J., Baur C., Josephi E., Beer G., et al. DNA analysis of HLA class II and III genes in sudden infant death (SIDS). Beitr. Gerichtl. Med. 1990, 48285-48290.
88. Summers A.M., Summers C.W., Drucker D.B., Hajeer A.H., Barson A., Hutchinson I.V. Association of IL-10 genotype with sudden infant death syndrome. Hum. Immunol. 2000, 61(12):1270-1273.
89. Opdal S.H., Opstad A., Vege A., Rognum T.O. IL-10 gene polymorphisms are associated with infectious cause of sudden infant death. Hum. Immunol. 2003, 64(12):1183-1189.
90. Moscovis S.M., Gordon A.E., Al Madani O.M., Gleeson M., Scott R.J., Roberts-Thomson J., et al. Interleukin-10 and sudden infant death syndrome. FEMS Immunol. Med. Microbiol. 2004, 42(1):130-138.
91. Perskvist N., Skoglund K., Edston E., Backstrom G., Lodestad I., Palm U. TNF-alpha and IL-10 gene polymorphisms versus cardioimmunological responses in sudden infant death. Fetal Pediatr. Pathol. 2008, 27(3):149-165.
92. Dashash M., Pravica V., Hutchinson I.V., Barson A.J., Drucker D.B. Association of sudden infant death syndrome with VEGF and IL-6 gene polymorphisms. Hum. Immunol. 2006, 67(8):627-633.
93. Moscovis S.M., Gordon A.E., Al Madani O.M., Gleeson M., Scott R.J., Roberts-Thomson J., et al. IL6 G-174C associated with sudden infant death syndrome in a Caucasian Australian cohort. Hum. Immunol. 2006, 67(10):819-825.
94. Opdal S.H., Rognum T.O. The IL6-174G/C polymorphism and sudden infant death syndrome. Hum. Immunol. 2007, 68(6):541-543.
95. Ferrante L., Opdal S.H., Vege A., Rognum T.O. TNF-alpha promoter polymorphisms in sudden infant death. Hum. Immunol. 2008, 69(6):368-373.
96. Opdal S.H., Rognum T.O., Vege A., Stave A.K., Dupuy B.M., Egeland T. Increased number of substitutions in the D-loop of mitochondrial DNA in the sudden infant death syndrome. Acta Paediatr. 1998, 87(10):1039-1044.
97. Opdal S.H., Vege A., Egeland T., Musse M.A., Rognum T.O. Possible role of mtDNA mutations in sudden infant death. Pediatr. Neurol. 2002, 27(1):23-29.
98. Divne A.M., Rasten-Almqvist P., Rajs J., Gyllensten U., Allen M. Analysis of the mitochondrial genome in sudden infant death syndrome. Acta Paediatr. 2003, 92(3):386-388.
99. Hofmann S., Jaksch M., Bezold R., Mertens S., Aholt S., Paprotta A., et al. Population genetics and disease susceptibility: characterization of central European haplogroups by mtDNA gene mutations, correlation with D loop variants and association with disease. Hum. Mol. Genet. 1997, 6(11):1835-1846.
100. Rahim R.A., Boyd P.A., inslie Patrick W.J., Burdon R.H. Human heat shock protein gene polymorphisms and sudden infant death syndrome. Arch. Dis. Child 1996, 75(5):451-452.
101. Forsyth L., Hume R., Howatson A., Busuttil A., Burchell A. Identification of novel polymorphisms in the glucokinase and glucose-6-phosphatase genes in infants who died suddenly and unexpectedly. J. Mol. Med. 2005, 83(8):610-618.
102. Cummings K.J., Klotz C., Liu W.Q., Weese-Mayer D.E., Marazita M.L., Cooper M.E., et al. Sudden infant death syndrome (SIDS) in African Americans: polymorphisms in the gene encoding the stress peptide pituitary adenylate cyclase-activating polypeptide (PACAP). Acta Paediatr. 2009, 98(3):482-489.
103. Stray-Pedersen A., Vege A., Opdal S.H., Moberg S., Rognum T.O. Surfactant protein A and D gene polymorphisms and protein expression in victims of sudden infant death. Acta Paediatr. 2009, 98(1):62-68.
104. Rand C.M., Weese-Mayer D.E., Maher B.S., Zhou L., Marazita M.L., Berry-Kravis E.M. Nicotine metabolizing genes GSTT1 and CYP1A1 in sudden infant death syndrome. Am. J. Med. Genet. A 2006, 140(13):1447-1452.
105. Hedley P.L., Jorgensen P., Schlamowitz S., et al. The genetic basis of long QT and short QT syndromes: a mutation update. Hum. Mutat. 2009, 30:1486-1511.
106. Vege A., Rognum T.O., Scott H., Aasen A.O., Saugstad O.D. SIDS cases have increased levels of interleukin-6 in cerebrospinal fluid. Acta Paediatr. 1995, 84:193-196.